Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FLURAZEPAM vs FLUTICASONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FLURAZEPAM vs FLUTICASONE: Safety Overview

Metric FLURAZEPAM FLUTICASONE
Total FAERS Reports 976 31,969
Deaths Reported 94 1,043
Death Rate 9.6% 3.3%
Hospitalizations 509 3,658
Average Patient Age 49.5 yrs 52.4 yrs
% Female Patients 66.4% 67.3%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 17, 2019
Manufacturer Chartwell RX, LLC GlaxoSmithKline LLC
Route ORAL RESPIRATORY (INHALATION)
Marketing Status Discontinued Discontinued